Autoinjector Device for Rapid Administration of Life Saving Drugs in Emergency (Review Paper)

R Vijayaraghavan


A number of emergency situations require immediate drug administration for reducing the morbidity and mortality. Autoinjectors are very useful devices for the rapid administration of the recommended drugs. They are well suited for emergency and mass casualty management, convenient to use and fast in action. A variety of autoinjectors are available viz., for nerve agent poisoning (atropine sulphate and pralidoxime chloride), anaphylactic shock (epinephrine), seizures (diazepam), and migraine (sumatriptan). The advantages of these autoinjectors are reviewed here with a focus on the requirement for autoinjectors for an antibacterial and an analgesic drug.

Defence Science Journal, 2012, 62(5), pp.307-314, DOI:


Autoinjector, nerve agent, anaphylaxis, atropine sulphate, pralidoxime chloride, epinephrine, diazepam, sumatriptan, amikacin, buprenorphine


Jain, Neeti; Kumar, Pravin; Kumar, Deo; Mavai, Yogendra & Vijayaraghavan, R. Development and evaluation of combined drug formulation for autoject-injector, for emergency application in organophosphate poisoning. Def. Sci. J., 2011, 62(2), 105-111.

Vijayaraghavan, R.; Jain, Neeti; Gautam, A.; Sharma, M.; Singh, Seema; Kumar, Deo; Singh, Ram; Kumar, Pravin; Gupta, A.K. & Jain, Suman. Evaluation of the antidotal efficacy of atropine sulphate and pralidoxime chloride given by autoinjectors against nerve agent (Sarin) toxicity. J. Med. C.B.R. Def., 2007, 5(1), 1-12.

Vijayaraghavan, R.; Bhaskar, A.S.B.; Gautam, A.; Gopalan, N.; Singh, A.K.; Beer Singh & Flora, S.J.S. A convenient first aid kit for chemical and biological agents and radiation exposure. J. Environ. Biol., 2012, 33(3), 673-681.

Friedl, K.E.; Hannan, C.J. Jr.; Schadler, P.W. & Jacob, W.H. Atropine absorption after intramuscular administration with 2-pralidoxime chloride by two automatic injector devices. J. Pharm. Sci., 1989, 78(9), 728-71.

Thiermann, H.; Radtke, M.; Spohrer, U.; Klimmek, R. & Eyer, P. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7. Arch. Toxicol., 1996, 70(5), 293-99.

Schlager, J.W.; Dolzine, T.W.; Stewart, J.R.; Wannarka, G.L. & Shih, M.L. Operational evaluation of three commercial configurations of atropine/HI-6 wet/dry autoinjectors. Pharm. Res., 1991, 8(9), 1191-194.

Spöhrer, U.; Thiermann, H.; Klimmek, R. & Eyer, P. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors. Arch. Toxicol., 1994, 68(8), 480-89.

Clair, P.; Wiberg, K.; Granelli, I.; Carlsson Bratt, I. & Blanchet, G. Stability study of a new antidote drug combination (Atropine-HI-6-Prodiazepam) for treatment of organophosphate poisoning. Eur. J. Pharm. Sci., 2000, 9(3), 259-63.

Nyberg, A.G.; Cassel, G.; Jeneskog, T.; Karlsson, L.; Larsson, R.; Lundstrom, M.; Palmer, L. & Persson, S.A. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector. Biopharm. Drug Dispos., 1995, 16(8), 35-51.

Nyberg, A.G.; Cassel, G.; Jeneskog, T.; Karlsson, L.; Larsson, R.; Lundstrom, M. & Persson, S.A. Treatment of organophosphate poisoning in pigs: Antidote administration by a new binary autoinjector. Arch. Toxicol., 1995, 70(1), 20-27.

van Helden, H.P.; Joosen, M.J. & Philippens, I.H. Non-enzymatic pretreatment of nerve agent (Soman) poisoning: a brief state-of-the-art review, Toxicol. Lett., 2011, 206(1), 35-40.

Baker, M.D. Antidotes for nerve agent poisoning: should we differentiate children from adults? Curr. Opin. Pediatr., 2007, 19(2), 211-215.

Corvino, T.F.; Nahata, M.C.; Angelos, M.G.; Tschampel, M.M.; Morosco, R.S.; Zerkle, J. & Nelson, R.N. Availability, stability, and sterility of pralidoxime for mass casualty use. Ann. Emerg. Med., 2006, 47(3), 272-277.

Combs, J.; Hise, L. & Copeland, R. High-pressure injection injury involving a 2-PAM chloride autoinjector. Mil. Med., 1992, 157(8), 434-436.

Taylor, C.L. & Taylor, S.F. Atropine autoinjector use as a suicidal gesture. J. Emerg. Med., 2008, 34(4), 397-400.

Levy, A.; Kushnir, M.; Chapman, S.; Brandeis, R.; Teitelbaum. Z. & Gilat, E. Characterization of early plasma concentrations of midazolam in pigs after administration by an autoinjector. Biopharm. Drug Dispos., 2004, 25(7), 297-301.

Lamson, M.J.; Sitki-Green, D.; Wannarka, G.L.; Mesa, M.; Andrews, P. & Pellock, J. Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study. Clin. Drug Investig., 2011, 31(8), 585-97.

Sicherer, S.H. & Simons, F.E. Section on Allergy and Immunology, American Academy of Pediatrics. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics, 2007, 119(3), 638-46.

Asero, R.; Antonicelli, L.; Arena, A.; Bommarito, L.; Caruso, B.; Colombo, G.; Crivellaro, M.; De Carli, M.; Della Torre, E.; Della Torre, F.; Heffler, E.; Lodi Rizzini, F.; Longo, R.; Manzotti, G.; Marcotulli, M.; Melchiorre, A.; Minale, P.; Morandi, P.; Moreni, B.; Moschella, A.; Murzilli, F.; Nebiolo, F.; Poppa, M.; Randazzos, S.; Rossi, G. & Senna. G.E. Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergenbased also? An Italian multi-centre study. Eur. Ann. Allergy Clin. Immunol., 2010, 42(1), 25-31.

Simons, F.E.; Clark, S. & Camargo, C.A. Jr. Anaphylaxis in the community: learning from the survivors. J. Allergy Clin. Immunol., 2009, 124(2), 301-306.

DeMuth, K.A. & Fitzpatrick, A.M. Epinephrine autoinjector availability among children with food allergy. Allergy Asthma Proc., 2011, 32(4), 295-300.

Flokstra-de Blok, B.M.; Doriene van Ginkel, C.; Roerdink, E.M.; Kroeze, M.A.; Stel, A.A.; van der Meulen, G.N. & Dubois, A.E. Extremely low prevalence of epinephrine autoinjectors in high-risk food-allergic adolescents in Dutch high schools. Pediatr. Allergy Immunol., 2011, 22(4), 374-77.

Olympia, R.P.; Wan, E. & Avner, J.R. The preparedness of schools to respond to emergencies in children: a national survey of school nurses. Pediatrics, 2005, 116(6), 738- 45.

Kljakovic, M.; Gatenby, P.; Hawkins, C.; Attewell, R.G.; Ciszek, K.; Kratochvil, G.; Moreira, A. & Ponsonby, A.L. The parent-reported prevalence and management of peanut and nut allergy in school children in the Australian Capital Territory. J. Paediatr. Child Health, 2009, 45(3), 98-103.

Alangari, A.A.; Twarog, F.J.; Shih, M.C. & Schneider, L.C. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics, 2004, 113(4), 313-17.

Simons, F.E.; Roberts, J.R.; Gu, X. & Simons, K.J. Epinephrine absorption in children with a history of anaphylaxis. J. Allergy Clin. Immunol., 1998, 101(1), 33-37.

Gold, M.S. & Sainsbury, R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J. Allergy Clin. Immunol., 2000, 106(1), 171-76.

Goldberg, A. & Confino-Cohen, R. Insect sting-inflicted systemic reactions: attitudes of patients with insect venom allergy regarding after-sting behavior and proper administration of epinephrine. J. Allergy Clin. Immunol., 2000, 106(6), 1184-189.

Johnson, R.F. & Peebles, R.S. Anaphylactic shock: pathophysiology, recognition, and treatment. Semin. Respir. Crit. Care Med., 2004, 25(6), 695-703.

Barton, E.C. Latex allergy: recognition and management of a modern problem. Nurse Pract., 1993, 18(11), 54-58.

Patel, O.P. & Simon, M.R. Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine. Int. Arch. Allergy Immunol., 2006, 140(1), 27 - 29.

Miller, C.W.; Guha, B. & Krishnaswamy, G. Exerciseinduced anaphylaxis: A serious but preventable disorder. Phys. Sportsmed., 2008, 36(1), 87-94.

Berteau, C.; Schwarzenbach, F.; Donazzolo, Y.; Latreille, M.; Berube, J.; Abry, H.; Cotten, J.; Feger, C. & Laurent, P.E. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers. Patient Prefer. Adherence, 2010, 5(4), 379-388.

Baker, T.W.; Webber, C.M.; Stolfi, A. & Gonzalez-Reyes, E. The ten study: time epinephrine needs to reach muscle. Ann. Allergy Asthma Immunol., 2011, 107(3), 235-238.

Schwirtz, A. & Seeger, H. Are adrenaline autoinjectors fit for purpose? A pilot study of the mechanical and injection performance characteristics of a cartridge-versus a syringe-based autoinjector. J. Asthma Allergy, 2010, 25(3), 159-67.

Song, T.T.; Nelson, M.R.; Chang, J.H.; Engler, R.J. & Chowdhury, B.A. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann. Allergy Asthma Immunol., 2005, 94(5), 539-42.

Arga, M.; Bakirtas, A.; Catal, F.; Derinoz, O.; Harmanci, K.; Razi, C.H.; Ergocen, S.; Demirsoy, M.S. & Turktas, I. Training of trainers on epinephrine autoinjector use. Pediatr. Allergy Immunol., 2011, 22(6), 590-93.

Bakirtas, A.; Arga, M.; Catal, F.; Derinoz, O.; Demirsoy, M.S. & Turktas, I. Make-up of the epinephrine autoinjector: the effect on its use by untrained users. Pediatr. Allergy Immunol., 2011, 22(6), 729-33.

Mrvos, R.; Anderson, B.D. & Krenzelok, E.P. Accidental injection of epinephrine from an autoinjector: invasive treatment not always required. South Med, J,, 2002, 95(3), 318-20.

McGovern, S.J. Treatment of accidental digital injection of adrenaline from an auto-injector device. J. Accid. Emerg. Med., 1997, 14(6), 379-80.

Mathez, C.; Favrat, B. & Staeger, P. Management options for accidental injection of epinephrine from an autoinjector: a case report. J. Med. Case Reports, 2009, 8(3), 7268-269.

Pytliak, M.; Vargova, V.; Mechirova, V. & Felsoci, M. Serotonin receptors - from molecular biology to clinical applications. Physiol. Res., 2011, 60(1), 15-25.

Goadsby, P.J. Serotonin receptor ligands: treatments of acute migraine and cluster headache. Handb. Exp. Pharmacol., 2007, 177(1), 129-43.

Russell, M.B.; Holm-Thomsen, O.E.; Rishøj Nielsen, M.; Cleal, A.; Pilgrim, A.J. & Olesen, J. A randomized doubleblind placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Cephalalgia, 1994, 14(4), 291-96.

Monstad, I.; Krabbe, A.; Micieli, G.; Prusinski, A.; Cole, J.; Pilgrim, A. & Shevlin, P. Preemptive oral treatment with sumatriptan during a cluster period. Headache, 1995, 35(10), 607-13.

Schoenen, J.; Bulcke, J.; Caekebeke, J.; Dehaene, I.; De Keyser, J.; Hildebrand, G.; Joffroy, A.; Laloux, P.; Louis, P. & Monseu, G. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study. Cephalalgia, 1994, 14(1), 55-63.

Exell, S.; Verdun, E. & Driebergen, R. A new electronic device for subcutaneous injection of IFN-?-1a. Expert. Rev. Med. Devices, 2011, 8(5), 543-53.

Phillips, J.T.; Fox, E.; Grainger, W.; Tuccillo, D.; Liu, S. & Deykin, A. An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects. B.M.C. Neurol., 2011, 14(11), 126-29.

Verdun di Cantogno, E.; Russell, S. & Snow, T. Understanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practices. Patient Prefer. Adherence, 2011, 5(3), 173-80.

Varunok, P.; Lawitz, E.; Beavers, K.L.; Matusow, G.; Leong, R.; Lambert, N.; Bernaards, C.; Solsky, J.; Brennan, B.J.; Wat, C. & Bertasso. A. Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device. Patient Prefer. Adherence, 2011, 5(11), 587-99.

Tauber, M.; Payen, C.; Cartault, A.; Jouret, B.; Edouard, T. & Roger, D. User trial of Easypod, an electronic autoinjector for growth hormone. Ann. Endocrinol (Paris)., 2008, 69(6), 511-16.

Shah, P.J.; Dinsmore, W.; Oakes, R.A. & Hackett, G. Injection therapy for the treatment of erectile dysfunction: A comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate. Curr. Med. Res. Opin., 2007, 23(10), 2577-583.

Schier, J.G.; Ravikumar, P.R.; Nelson, L.S.; Heller, M.B.; Howland, M.A. & Hoffman, R.S. Preparing for chemical terrorism: stability of injectable atropine sulphate. Acad. Emerg. Med., 2004, 11(4), 329-34.

Gill, M.A.; Kislik, A.Z.; Gore, L. & Chandna, A. Stability of advanced life support drugs in the field. Am. J. Health Syst. Pharm., 2004, 61(6), 597-602.

Hoffman, R.S.; Mercurio-Zappala, M.; Bouchard, N.; Ravikumar, P. & Goldfrank, L. Preparing for Chemical Terrorism: A Study of the Stability of Expired Pralidoxime (2-PAM). Disaster. Med. Public. Health Prep., 2012, 6(1), 20-25.

Schroeder, A.C.; DiGiovanni, J.H.; Von Bredow, J. & Heiffer, M.H. Pralidoxime chloride stability-indicating assay and analysis of solution samples stored at room temperature for ten years. J. Pharm. Sci., 1989, 78(2), 132-36.

Simons, F.E.; Gu, X. & Simons, K.J. Outdated EpiPen and EpiPen Jr autoinjectors: past their prime? J. Allergy Clin. Immunol., 2000, 105(5), 1025-1030.

Cunha, B.A. Aminoglycosides: current role in antimicrobial therapy. Pharmacotherapy, 1988, 8(6), 334-50.

Gonzalez, L.S. & Spencer, J.P. Aminoglycosides: a practical review. Am. Fam. Physician., 1998, 58(8), 1811-820.

Bovill, J.G. Which potent opioid? Important criteria for selection. Drugs, 1987, 33(5), 520-30.


CC License Except where otherwise noted, the Articles on this site are licensed under Creative Commons License: CC Attribution-Noncommercial-No Derivative Works 2.5 India

Copyright © 2015, Defence Scientific Information & Documentation Centre (DESIDOC), All Rights Reserved.